HomeClinical TopicsFDA releases recommendations to reduce risk of Zika virus blood transmission

FDA releases recommendations to reduce risk of Zika virus blood transmission

On Feb. 17, the Food and Drug Administration (FDA) issues recommendations to reduce the risk of transmission of the Zika virus through blood transfusion. The FDA recommends deferral of individuals from donating blood if they have been to areas with active Zika virus transmission, potentially have been exposed to the virus, or have had a confirmed Zika virus infection. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Couple talking to NP

Getting Covid Vaccine Won’t Hurt Pregnancy Chances; Getting Covid Could

Couples planning a pregnancy might be relieved to know that getting a Covid vaccine does not hurt their odds of conceiving, according to the...